Two studies on the genome of the coronavirus in India conducted by the country’s top clinical research body and the Department of Bio-Technology suggest that the COVID-19 virus is genetically stable and has shown no major mutation, the Prime Minister’s office said on Saturday.
There had been some concern that any major mutation detected in the novel coronavirus could affect the development of an effective vaccine. However, some recent global studies have said the vaccines currently being developed for COVID-19 should not be affected by these mutations.
Mutation typically refers to the property of a virus to change when it multiplies and the virus may develop some new strains after it replicates. In cases, the new strains tend to be less effective and therefore die out soon, while more powerful strains may lead to faster spread of the virus.
After a review meeting chaired by Prime Minister Narendra Modi on the COVID-19 pandemic situation, and vaccine delivery, distribution and administration preparedness, the Prime Minister’s Office said in a statement that three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III.
- US sees daily record of nearly 80,000 new COVID-19 cases - October 24, 2020
- Vitamin A Boosts Fat Burning In Cold Conditions, Study Shows Hope For Obesity | मोटापा के इलाज की जगी उम्मीद, शोध में खुलासा - October 24, 2020
- Anesthetic Uses, Addiction & Withdrawal - October 24, 2020
- Biden pledges free Covid vaccine for ‘everyone’ in US if elected - October 24, 2020
- Tips For Relief: Do You Face Upper Back Pain? Try These Tips To Combat - October 24, 2020
- Survival Rate for Acute Lymphoblastic Leukemia - October 24, 2020
- Europe surges again this week - October 24, 2020
- Could Common Asthma Meds Weaken Bones? - October 24, 2020
- Over 53,000 New Cases In A Day As India’s Covid Tally Passes 78 Lakh-Mark - October 24, 2020
- Team Gemini gives disabled children something to cheer about - October 24, 2020